The Insulin and IGF Signaling Pathway Sustains Breast Cancer Stem Cells by IRS2/PI3K-Mediated Regulation of MYC

Authors

Ji-Sun Lee
Michael W Lero
Jose Mercado-Matos
Sha Zhu
Minjeong Jo
Claire E Tocheny
Jennifer S Morgan
Leslie M Shaw

Publication Date

12-6-2022

Journal

Cell Reports

Abstract

Despite the strong association of the insulin/insulin-like growth factor (IGF) signaling (IIS) pathway with tumor initiation, recurrence, and metastasis, the mechanism by which this pathway regulates cancer progression is not well understood. Here, we report that IIS supports breast cancer stem cell (CSC) self-renewal in an IRS2-phosphatidylinositol 3-kinase (PI3K)-dependent manner that involves the activation and stabilization of MYC. IRS2-PI3K signaling enhances MYC expression through the inhibition of GSK3β activity and suppression of MYC phosphorylation on threonine 58, thus reducing proteasome-mediated degradation of MYC and sustaining active pS62-MYC function. A stable T58A-Myc mutant rescues CSC function in Irs2−/− cells, supporting the role of this MYC stabilization in IRS2-dependent CSC regulation. These findings establish a mechanistic connection between the IIS pathway and MYC and highlight a role for IRS2-dependent signaling in breast cancer progression.

Keywords

Insulin, Phosphatidylinositol 3-Kinase, Phosphatidylinositol 3-Kinases, Somatomedins, Neoplastic Stem Cells, Signal Transduction, Neoplasms

Comments

Supplementary Materials

PMID: 36476848